Chondrodysplasia punctata (CDP) is a group of rare congenital skeletal dysplasias, heterogeneous both in their clinical expression and in their genetic basis. It is characterized by anomalous stippled (punctate) calcification in cartilaginous parts of the developing skeleton, observable by radiological imaging, which constitute its distinctive feature.
On radiographic imaging, CPD shows epiphyseal punctuation in multiple areas of the axial and appendicular skeleton, with variable distribution and severity depending on the specific subtype. These calcifications may compromise normal cartilage growth and bone development, leading to skeletal alterations including shortened long bones, vertebral malformations, multiple dysostosis, and craniofacial abnormalities.
From a genetic standpoint, CDP comprises several hereditary forms which may follow X-linked, autosomal dominant, and autosomal recessive transmission patterns, as well as sporadic cases. Each form shows a specific inheritance pattern, age of onset, and prognosis; therefore, an accurate diagnosis requires a combination of clinical assessment, imaging studies, and molecular genetic testing.
Early detection of this entity is essential, as many CPD forms are associated with multisystem complications such as congenital cataracts, respiratory dysfunction, nasal bone hypoplasia, and developmental delay. A multidisciplinary approach involving medical genetics, orthopedics, pediatrics, and other medical specialties is essential for integrated patient management.
Are you a healthcare professional?
This content is intended exclusively for healthcare professionals.
The content is for informational purposes only and is not intended for the general public.
